Both firms have announced that top-line results from a phase 3 study assessing tanezumab 2.5mg and 5mg. Tanezumab is an investigational monoclonal antibody, which works by selectively targeting, The post Pfizer, Lilly’s painkiller tanezumab shows mixed results in phase 3 osteoarthritis trial appeared first on Pharmaceutical Business review.

As per terms of the deal, twoXAR will apply its AI discovery technology to identify a set of initial candidates to treat lung cancer through novel biological mechanisms The post SK Biopharmaceuticals, twoXAR collaborate to develop treatments for NSCLC appeared first on Pharmaceutical Business review.

LabCorp said that the proposed deals will make the company to pay a net cash of $485m and will add an incremental $156m to revenues on a pro The post LabCorp to buy Envigo’s non-clinical research services business in $485m deal appeared first on Pharmaceutical Business review.

Based in Athens of Greece, Genepharm is involved in the development, manufacturing and out-licensing of high-value generic pharmaceutical products. The company, which owns a wide portfolio of products, The post MS Pharma to acquire European pharmaceutical firm Genepharm appeared first on Pharmaceutical Business review.

Under the three-year deal, the partnership will use insitro’s platform to create disease models for NASH and discover targets that can impact clinical progression and regression of the The post Gilead, insitro collaborate to develop therapies for nonalcoholic steatohepatitis appeared first on Pharmaceutical Business review.